20 (AIDX) Net Income towards Common Stockholders (2025 - 2026)
20 (AIDX) posted Net Income towards Common Stockholders of -$2.1 million for Q1 2026, down 177.36% on a QoQ basis from -$764577.0 in Q1 2025, and down 177.36% year-over-year from $2.7 million in Q1 2025.
20 (AIDX) Net Income towards Common Stockholders (2025 - 2026) Analysis & Trends
20's Net Income towards Common Stockholders history runs 2 years deep, the most recent figure standing at -$2.1 million for Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 177.36% year-over-year to -$2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.9 million (changed N/A YoY) and the FY2025 annual result came in at -$3.8 million, up 30.86% from the prior year.
- Net Income towards Common Stockholders was -$2.1 million for Q1 2026 at 20, down from -$764577.0 in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at -$764577.0 in Q1 2025 and bottomed at -$2.1 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 68.63 Bn | 67.18 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.43 Bn | 44.76 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 28.14 Bn | 25.85 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.25 Bn | 21.12 Bn | 2.07 Bn | 176.78 Mn |
| 10 | 20 | 3.45 Mn | -772,580.19 | 62,884.00 | -2.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.12 Mn |
| Mar 31, 2025 | -764,577.00 |